Donna M. Wilcock, PhD is the Sweeney-Nelms Professor in Alzheimer’s Disease Research at the Sanders-Brown Center on Aging and Professor in the Department of Physiology at the University of Kentucky. Dr. Wilcock was received her Bachelor’s degree in Pharmacology from Cardiff University. She obtained her Ph.D. at the University of South Florida, and completed postdoctoral training at Albert Einstein College of Medicine and Duke University. Dr. Wilcock’s research is focused on vascular cognitive impairment and dementia (VCID), a common cause of dementia and frequent co-morbidity with Alzheimer’s disease pathology. She is performing translational research on VCID, ranging from studying molecular mechanisms through identification of novel biomarkers in patients. She is primarily focused on inflammatory and angiogenic processes, as well as studying the influence VCID has on the progression and severity of Alzheimer’s disease. Her work is funded by the National Institute on Aging and the National Institute on Neurological Disorders and Stroke.

This event is designed to showcase dementia research in Wessex, celebrate the launch of iDeAC, link dementia researchers across Wessex and grow the network for clinical trials. There will be a particular focus on early career researchers and highlighting research opportunities at all points in the dementia and brain ageing pathway.
Intended outputs of this event will include collaboration of future research projects, grant applications and better translation of clinical research into clinical care. It will be delivered by IDeAC, NIHR and ARC Wessex.

Masafumi Ihara, MD, PhD, National Cerebral and Cardiovascular Center: Suita, Osaka will be giving the keynote lecture “Cilostazol treatment for Alzheimer’s disease”at the next iDeac meeting to be held on the 20th August at the Univesuty of Southampton. Other speakers include;

The Alzheimer’s Association International Conference® is the largest and most influential international meeting dedicated to advancing dementia science. Each year, AAIC® convenes the world’s leading basic science and clinical researchers, next-generation investigators, clinicians and the care research community to share research discoveries that’ll lead to methods of prevention and treatment and improvements in the diagnosis of Alzheimer’s disease.